Vivax Working Group

26-28 September, 2011Wuxi, China

As an outcome of the Annual Vivax Working Group meeting in May 2011, an additional workshop was held to seek the interest of APMEN countries in participating a multicentre primaquine clinical trial - to build research capacity in countries with less research experience.

Delegates from the National Malaria Control Programs from APMEN countries and partner institutions met in September 2011 in Wuxi, China to plan a multicentre vivax treatment trial to improve anti-relapse treatment guidelines. There was broad agreement that such a trial would need to follow patients for at least 12 months after initial treatment of blood stage infection.

Meeting Materials